medical tests and what they mean -...
TRANSCRIPT
11/25/13
1
Medical Tests and What they Mean
James L. Coyle, Ph.D., CCC-‐SLP
Department of Communica@on Science & Disorders
University of PiEsburgh
Chest imaging, pneumonia differen@al diagnosis, bloodwork
1
Pneumonia, inadequate nutri/on,
dehydra/on
Dysphagia-‐ aspira/on
Pulmonary disease
Diges/ve diseases
Iatrogenic disorders
Neurological diseases
2
Aging, Frailty
Dysphagia
Another Disease
Disease
Dysphagia and disease
3
11/25/13
2
Dysphagia and disease
Disease
Pulmonary Iatrogenic Neurologic Diges@ve & Other
Dysphagia
4
Medical Tests and their Meanings
• 1. Chest imaging • Chest X-‐ray • Chest axial scans (CT)
• 2. Imaging findings in reports • 3. Bloodwork:
• Arterial blood gases, WBC, Pulse oximetry • bacteriology
• 4. Pneumonia findings of interest • 5. Introduc@on to medica@ons
5
Chest Imaging
• Chest x-‐ray • Chest CT
6
11/25/13
3
Chest x-ray
• Shadows • X-‐rays penetrate air filled areas and strike film
• X-‐rays are absorbed by denser @ssue
• Differences in grayscale color indicate areas of “more solid” maEer
• Causes a “shadow” on the film 7
Chest CT • Slices of body part are looked at
8
Rostral (toward head)
Caudal (toward feet)
Anterior (front surface)
Images © Nevit Dilmen
Normal
Pneumonia
Public domain: hEp://upload.wikimedia.org/wikipedia/commons/a/a6/Pneumonia_x-‐ray.jpg 9
11/25/13
4
RUL, RML, RLL, LLL OVERLAP RUL+RLL OVERLAP RML+RLL
Posterior Anterior Right Le@
Right lung
3
10
Anterior Posterior Right Le@
LUL, LLL OVERLAP LUL + LLL
Leg lung
11
Chest x-ray reports • Terms
• Consolida@on, density, opacity: • “there is a shadow indica@ng something denser than air.”
• Infiltrates: • More solid maEer has infiltrated an air-‐filled space
• Alveolar, airway • Edema: Fluid satura@ng area
• Alveolar, inters@@al • Effusion: fluid fills a body cavity (pleural)
12
11/25/13
5
Chest x-ray reports
• Terms • Pulmonary vascular conges@on
• NOT airway conges@on • Blood back-‐up in pulmonary vessels
• Alveolar infiltrates are inside alveoli! • The rest of these are NOT alveolar infiltrates.
13
Chest x-ray • Costophrenic angles: intersec@on between chest wall and diaphragm
• Costo = ribs • Phrenic = diaphragm
• Blunted costophrenic angles
• Typically” pleural effusions
Image © Aldan Jones
14
Pleural effusion • Fluid filling parts of pleural cavity • Preven@ng lung expansion during inspira@on • Gravity dependent “bag of water”
Pleural cavity
15
11/25/13
6
Pleural Effusions
Images public domain
Costophrenic angle 16
Chest x-ray
• Cardiac sillouheEe • Shadow of the heart
• Cardiomegaly
Image © Aldan Jones
Image © Nevit Dilmen 17
Chest x-ray reports • Atelectasis: collapsed alveoli
• Obstruc@ve • Blocked airways; gas within alveoli absorbed into blood
• Non-‐obstruc@ve • Compressive • Dependent
• Pt. posi@on prevents infla@on of alveoli; poor inspira@on
• Adhesive: lack of surfactant cause collapse • Passive: widened pleural space enables collapse
18
11/25/13
7
Atelectasis
Image © MaEeo Di Nardo, Daniela PerroEa, Francesca Stoppa, Corrado Ceccheo, Marco Marano and Nicola Pirozzi
(R) Apical (apex)
(L) basal (inferior)
Infant with RSV pneumonia
19
Pneumothorax
• Perfora@on of pleural membrane • Destroys intrapleural vacuum that holds lung open
Subatmospheric pressure
Pleural cavity
Atmospheric pressure 20
Pneumothorax
© en:User:Clinical Cases
© Hellerhoff
21
11/25/13
8
Pulmonary edema
• Leakage of circulatory fluid into alveoli • Most common cause = conges@ve heart failure • Pulmonary hypertension “pushes” fluid out of capillaries
Pulmonary hypertension
22
Pulmonary edema • Other causes
• Intra-‐alveolar hyperosmolality • Contents of alveoli are “hypertonic” compared to body fluids
• Fluid “osmosis” into alveoli to equalize osmo@c pressure
• Net fluid volume increase within alveoli
• Aspira@on of strongly hypertonic materials • Some Foods! • Sea water drowning syndrome (NaCl in sea water) • Some nonionic contrast agents (Gastrografin)
23
24
Pulmonary edema in massive pneumoni@s (ARDS – sepsis) (NON-‐CARDIOGENIC PULMONARY EDEMA)
Image pubic domain
11/25/13
9
Bloodwork
• WBC: normal value = ~4.500 – 11,000 c/mcl • Neutrophils: most abundant, first line WBC • First WBC to fight infec@on
• Segmented: mature; bands: immature • >1500 cells/mcl
25
Blood Gases • Arterial blood gases & normal ranges
• paCO2 = par@al pressure of CO2: 38-‐45 mmHg • paO2 = par@al pressure of O2: 85-‐100 mmHg • pH: acidity: ~7.4
26
Oxygen saturation • SaO2 = % hemoglobin O2 satura@on: 90-‐100%
• SpO2 = pulse oximetry (es@mate of SaO2) • Red & infrared light
• More red absorbed: less O2 • More infrared absorbed: more O2 satura@on
27
11/25/13
10
Bacteriology
• Sputum sample • Nondiagnos@c for aspira@on pneumonia if…
• Sample obtained at bedside (“spit into this cup…”)
• Diagnos@c for may other diagnoses • Protected specimen brush (PSB) or trap are reliable
• …for evidence of oral coloniza@on of lung • HOWEVER…requires bronchoscopy
28
Summary chest imaging/bloodwork • Radiographic signs reflect pathology
• They may, or may not explain/support • Respiratory func@on of pa@ent • Likelihood that dysphagia is a poten@al factor
• Bloodwork • Arterial gases reflect respiratory func@on
• May explain abnormal respiratory signs • WBC, sputum are clues: is it pneumonia?
29
Pneumonitis and Pneumonia
30
11/25/13
11
Pneumonitis: lung inflammation
31
Inflamma/on
Chemical Medica/ons
Irritant trauma/zes lung
Irritants, Allergens
Radia/on Therapy
Inhaled or aspirated sources
EDEMA
Pneumonia: lung infection
32
Pneumonia (Infec/on and Pneumoni/s)
Pathogen Colonizes lung
Bacterial
Inhaled or aspirated or hematogenous sources
Systemic Spread
Resolu@on
Sepsis, Hypotension, Mul@-‐organ Failure, Shock
Viral With or without other debris
Infec/on causes inflamma/on: pneumonia = infec/on + inflamma/on Pathogens and their waste are irritants
Pneumonia
33 Bilateral, mul@lobar infiltrates
Na@onal Cancer Ins@tute
11/25/13
12
Pneumonia with effusions
34
Infiltrates
Cavita/ons (abscess)
effusions
Inage: GNU free documenta@on license
Is pneumonia related to dysphagia? • Pa@ent MUST have dysphagia!
• A diagnosis known to produce dysphagia
• Dysphagia must precede the pneumonia
• Frail people with pneumonia develop ACUTE dysphagia
35
Summary
• Not all pneumonias are related to dysphagia • Signs of pneumonia are found in the medical record
• Importance of connec@ng the dots to ensure • We are managing dysphagia-‐related pneumonia and not…
• PNEUMONIA-‐RELATED DYSPHAGIA
36
11/25/13
13
Medications and their effects
37
Neuropharmacological Actions • Medica@ons alter membrane ac@vity at the synapse
• Presynap@c Changes • increased/decreased produc@on, storage, release • increased/decreased Ca++ channel flow
• Postsynap@c Changes • s@mula@on/blocking of receptor sites
• Metabolic Changes (Synap@c Cleg) • speeding/slowing of NT reuptake
38
Action Potential Transmission by Neurotransmitters animation (NIH) http://science.education.nih.gov/supplements/nih2/addiction/activities/lesson2_neurotransmission.htm
Neuropharmacological Actions • 1. Increase/ decrease NT in Pre-‐S.T.
• 2. Presynap@c inhibi@on or facilita@on
• assoc. neuron synapse proximal to target synapse
• 3. Enhancement or inhibi@on of NT re-‐absorp@on or metabolism
• 4. Similarly “shaped” molecule binds to receptors
• Receptor facilita@on • Agonist
• Receptor inhibi@on • Antagonist 39
1
2
2
3
4
11/25/13
14
Neuron Anatomy and Physiology
• Neuromuscular junc@on
• Similar ac@vity except…
• Post-‐synap@c terminal is MUSCLE
40
1. presynaptic terminal 2. sarcolemma 3. synaptic vesicles 4. Acetylcholine receptors 5. mitchondrion
© Dake, GNU Free Documenta@on License
Neuromuscular junc@on
Neuropharmacological Actions
• Most medica@ons are designed to perform one or more of these ac@ons at the synap@c level.
• Synap@c site predicts physiologic change resul@ng from medica@on ac@ons
41
Medications affecting swallowing • Mental status changes • Skeletal muscle func@on
• Contrac@lity • Neuromuscular junc@on ac@vity
• Coordina@on • Smooth muscle func@on • LES res@ng pressure and func@on • Salivary flow • Esophageal injury • Mimicking signs and symptoms, anorexia
42
11/25/13
15
Acid suppression medications
43
Gastric colonization
• Aggressive acid suppression may create condi@ons favoring pathogenesis of pneumonia*
• PPI: >2 @mes increase in pneumonia risk, incidence • Ambulatory and hospitalized pa@ents
• H2 blockers: increased risk (lower risk)
• Sucralfate (Carafate) subs@tute
• CDC advisory: PPI and C. difficile
*Marik, 2001; Marik and Zaloga, 2002; Laheij, et al., 2004; Eurich, 2010; Herzig et al., 2009 44
Thank you.
• All images used in this presenta@on are public domain, or licensed under Crea@ve Commons AEribu@on (Share-‐Alike 3.0 or Generic 2.5) License, CeCILL, or GNU Free Documenta@on license.
45